Peptides · Peptide comparison
Fertirelin vs Triptorelin
A potent GnRH analog designed to support reproductive function in veterinary and research settings
GnRH agonist that helps manage prostate cancer, endometriosis, and early puberty by controlling sex hormones
- Hormone Support
- Hormone Support
At a glance
Quick comparison
Efficacy
Benefit ratings
Reproductive Synchronization
Hormone Support
Veterinary Breeding Enhancement
Hormone Regulation
Cancer Management
Endometriosis Relief
Technical data
Compound specifications
Fertirelin
- Molecular formula
- C55H76N16O12
- Molecular weight
- 1153.3 g/mol
- Half-life
- Variable depending on formulation; sustained-release formulations extend duration
- Bioavailability
- High when administered via injection
- CAS number
- 66002-66-2
Triptorelin
- Molecular formula
- C64H82N18O13
- Molecular weight
- 1311.4 g/mol
- Half-life
- 2-3 hours (free peptide); 2-4 weeks (depot pamoate formulations)
- Bioavailability
- ~100% (intramuscular/subcutaneous injection)
- CAS number
- 57773-63-4
Protocols
Dosing compared
Fertirelin
Intramuscular
- 50-100 mcg per animalSingle injection at the defined point in the synchronization protocol · Single dose (repeated per breeding cycle as needed)Fertirelin is a veterinary GnRH agonist. In dairy cattle, 50 mcg and 100 mcg intramuscular both triggered an LH surge and comparable conception rates for ovulation synchronization and fixed-time insemination [4]. Used to induce ovulation and improve conception in cattle [1].
Triptorelin
Intramuscular injection
- 3.75 mgOnce every 4 weeks · Ongoing while indicatedFDA-labeled 1-month depot (Trelstar) for advanced prostate cancer; single IM injection into either buttock [5].
- 11.25 mgOnce every 12 weeks · Ongoing while indicatedFDA-labeled 3-month depot (Trelstar). Strengths are not additive; chosen by desired interval [5].
- 22.5 mgOnce every 24 weeks · Ongoing while indicatedFDA-labeled 6-month depot (Trelstar for prostate cancer; Triptodur 22.5 mg for central precocious puberty, ages 2+) [5][6].
Applications
Best suited for
Fertirelin
- Livestock breeding programs
- Fertirelin is particularly well-suited for individuals focused on livestock breeding programs. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Reproductive synchronization in cattle
- Fertirelin is particularly well-suited for individuals focused on reproductive synchronization in cattle. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Fertility enhancement in veterinary settings
- Fertirelin is particularly well-suited for individuals focused on fertility enhancement in veterinary settings. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Research on reproductive hormone mechanisms
- Fertirelin is particularly well-suited for individuals focused on research on reproductive hormone mechanisms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Triptorelin
- Managing advanced prostate cancer when combined with other treatments
- Triptorelin is particularly well-suited for individuals focused on managing advanced prostate cancer when combined with other treatments. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Relieving severe endometriosis pain and symptoms
- Triptorelin is particularly well-suited for individuals focused on relieving severe endometriosis pain and symptoms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Delaying puberty development in children with early sexual maturation
- Triptorelin is particularly well-suited for individuals focused on delaying puberty development in children with early sexual maturation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Safety profile
Side effects
Fertirelin
Common
- Mild discomfort at treatment site
- Transient hormone fluctuations
- Temporary behavioral changes in animals
- Mild injection site reactions
- Short-term changes in appetite
- Temporary mood variations
- Minimal systemic effects at therapeutic doses
Uncommon
- Occasional swelling at injection site
Serious
- Severe allergic reaction
Triptorelin
No side effects recorded.
Research status
Safety & evidence
Fertirelin
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Research compound
- Safety overview
- Fertirelin is a GnRH agonist developed specifically for veterinary use in livestock, particularly cattle breeding and fertility management. The peptide has been safely used in veterinary medicine for over 40 years with a well-documented safety profile in animals. Important limitation: Fertirelin is NOT approved for human use. All safety and efficacy data comes from veterinary applications in cattle and limited laboratory research. Human safety data is minimal and extrapolation from veterinary use is problematic. The biphasic response (initial hormone surge followed by suppression) must be carefully managed in any application. Individual responses can vary significantly based on age, hormonal status, and concurrent medications.
Contraindications
- Pregnancy (may disrupt existing pregnancy)
- Hypersensitivity to GnRH analogs
- Active reproductive infections
- Concurrent use with certain medications
- Undiagnosed reproductive disorders
Triptorelin
- Evidence level
- Strong human trials (Phase 3 or FDA approved)
- FDA status
- FDA approved for this use
- Safety overview
- Triptorelin (GnRH agonist) has extensive FDA-approved safety data spanning decades for prostate cancer, endometriosis, and precocious puberty indications. Initial testosterone surge upon initiation ("flare reaction") can worsen prostate cancer or spinal cord compression symptoms, requiring careful patient monitoring in first 1-2 weeks and use of androgen antagonists in high-risk patients. Hypogonadal effects including hot flashes, sexual dysfunction, and bone loss develop predictably with chronic GnRH suppression; bone density monitoring is recommended in patients on therapy >6 months.
Contraindications
- Pregnancy (can affect fetal development)
- Undiagnosed vaginal bleeding
- Known hypersensitivity to GnRH agonists
- Severe untreated depression
- Active spinal cord compression in prostate cancer (requires urgent decompression)
Decision guide
Which is right for you?
Fertirelin
Choose Fertirelin if…
- Livestock breeding programs
- Reproductive synchronization in cattle
- Fertility enhancement in veterinary settings
- Research on reproductive hormone mechanisms
Triptorelin
Choose Triptorelin if…
- Managing advanced prostate cancer when combined with other treatments
- Relieving severe endometriosis pain and symptoms
- Delaying puberty development in children with early sexual maturation